Skip to main content

College of Pharmacy

College of Pharmacy

Faculty Profile

Moosa TatarMoosa Tatar

Assistant Professor of Pharmaceutical Health Outcomes and Policy
Department of Pharmaceutical Health Outcomes and Policy

Office: 
University of Houston College of Pharmacy
Health 2, Room 4053
4349 Martin Luther King Boulevard
Houston, TX 77204-5047

Contact: mtatar@Central.UH.EDU - 832-842-8392

Research:

Tatar's research focuses on the use of large-scale empirical datasets to explore public health issues and evaluate health policies. From an interdisciplinary standpoint, his research combines data science approaches with applied econometric methods to predict and model public health policy and health care issues. Tatar applies these methods to analyze the effects of policymakers' decisions on complex public health problems, particularly focusing on causes of death, including opioid overdoses, COVID-19 and Diabetes. The goal of His research is to achieve health equity, eliminate disparities and improve health.  Tatar’s research on these areas has informed the impacts of policies on outcomes of treatment interventions, patterns of care and health care costs.

  • Ph.D., Health Services Research, Administration and Policy, University of Nebraska Medical Center, Omaha, Nebraska, USA
  • Ph.D., Economics, Public Sector Economics, University of Mazandaran, Babolsar, Iran
  • M.A., Economics, Planning and Analysis of Economic Systems, Azad University, Science and Research Branch, Tehran, Iran
  • B.A., Economics, Industrial Economics, University of Sistan and Baluchistan, Zahedan, Iran

Google Scholar Profile

Peer-reviewed Journal Articles

  • Tatar M, Faraji M, Wilson FA, Keyes K, Jalali MS. Social Vulnerability Predictors of Drug Poisoning Mortality: A Nationwide, Machine Learning Analysis in the United States. American Journal on Addictions. DOI: 10.1111/ajad.13445
  • Tatar M, Faraji M. Wilson FA. Social Vulnerability and Initial COVID-19 Community Spread in the US South: A Machine Learning Approach. BMJ Health & Care Informatics.
  • Tatar M, Montazeri Shoorekchali J, Faraji M, Abdi Seyyedkolaee M, Pagán J, Wilson FA. COVID-19 Vaccine Inequality: A Global Perspective. Journal of Global Health. 2022;12:03072. doi: 10.7189/jogh.12.03072
  • Habibdoust A, Tatar M, Wilson FA. Estimating Excess Deaths by Race/Ethnicity in the State of California During the COVID-19 Pandemic. Journal of Racial and Ethnic Health Disparities. 2022; 1- 13. doi: https://doi.org/10.1007/s40615-022-01349-9
  • Tatar M, Faraji M, Montazeri Shoorekchali J, Pagán, J, Wilson FA. The Role of Good Governance in the Race for Global Vaccination during the COVID-19 Pandemic. Scientific Reports. 2021; 11, 22440. doi:https://doi.org/10.1038/s41598-021-01831-0 10.
  • Mollalo A, Tatar M. Spatial Modeling of COVID-19 Vaccine Hesitancy in the United States. International Journal of Environmental Research and Public Health. 2021; 18(18):9488. doi: https://doi.org/10.3390/ijerph18189488
  • Tatar M, Montazeri Shoorekchali J, Faraji M, Wilson FA. International COVID-19 Vaccine Inequality Amid the Pandemic: Perpetuating a Global Crisis?. Journal of Global Health. 2021;11:03086. doi:10.7189/jogh.11.03086
  • Tatar M, Habibdoust A. Wilson FA. Excess Deaths Reveal the Substantial Impact of COVID-19 Pandemic on Mortality in the State of Florida, 2021:e1–e2. American Journal of Public Health. doi:https://doi.org/10.2105/AJPH.2021.306340
  • Tatar M, Wilson FA. The Largest Vaccination Campaign in History: A Golden Opportunity for Bundling Public Health Interventions. Journal of Global Health. 2021;11:03076. doi: 10.7189/jogh.11.03076
  • Tatar M, Jalali MS, Tak HJ, Chen LW, Araz OM, Wilson FA. Impact of Florida’s Prescription Drug Monitoring Program on Drug-Related Fatal Vehicle Crashes: a Difference-in-Differences Approach. Injury Prevention, 2022; 28(2), 105-109. doi: 10.1136/injuryprev-2020-044113.
  • Tatar M, Habibdoust A. Wilson FA. Analysis of excess deaths during the COVID-19 pandemic in the State of Florida. American Journal of Public Health. 2021 Apr;111(4):704-707. doi:10.2105/AJPH.2020.306130.
  • Tatar M, Keeshin SW, Mailliard M, Wilson FA. Cost-Effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States. JAMA Network Open. 2020:3(9):e2015756. doi:10.1001/jamanetworkopen.2020.15756.
  • Wilson FA, Zallman L, Pagán JA, Ortega AN, Wang Y, Tatar M, Stimpson JP. Health Care Utilization and Spending for Unauthorized Immigrants in the US: An Application of Machine Learning. JAMA Network Open. 2020;3(12):e2029230. doi:10.1001/jamanetworkopen.2020.29230.
  • Jafari Samimi A, Karimi S, Mohammadi T, Tatar M. Estimating willingness to pay for supplementary health insurance: Applications of the contingent valuation method and logit regression model. Comparative Economics. Iran. 2019: 6(1), 61-80. 3
  • Jafari Samimi A, Montazeri Shoorekchali J, Tatar M. Life Expectancy, and Economic Growth in Iran: Smooth Transition Regression (STR) Approach. Journal of Economic Growth and Development. Payam-e Noor University, Iran. 2013;13(1):117-128.
  • Member: Society for Medical Decision Making, AcademyHealth, System Dynamics (SD) Society, American Public Health Association, National Research Mentoring Network
  • Ad Hoc Reviewer: Drug and Alcohol Dependence, Injury Prevention, JAMA Pediatrics, American Journal of Preventive Medicine, Journal of Mathematical Modeling, Value in Health Regional Issues, Open Forum Infectious Diseases, BMJ Open, Psychology, Health & Medicine, Health Systems, Annals of Translational Medicine, and International Journal of Health Policy and Management